These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16566434)

  • 1. Lessons learned from gene therapy concerning and the use of integrating vectors and the possible risk of insertional oncogenesis.
    Cichutek K
    Dev Biol (Basel); 2006; 123():29-34; discussion 55-73. PubMed ID: 16566434
    [No Abstract]   [Full Text] [Related]  

  • 2. Fragile sites are preferential targets for integrations of MLV vectors in gene therapy.
    Bester AC; Schwartz M; Schmidt M; Garrigue A; Hacein-Bey-Abina S; Cavazzana-Calvo M; Ben-Porat N; Von Kalle C; Fischer A; Kerem B
    Gene Ther; 2006 Jul; 13(13):1057-9. PubMed ID: 16511518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications.
    Kang EM; Tisdale JF
    Curr Hematol Rep; 2004 Jul; 3(4):274-81. PubMed ID: 15217557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it going to be SIN?: a European Society of Gene Therapy commentary. Phasing-out the clinical use of non self-inactivating murine leukemia virus vectors: initiative on hold.
    Buchholz CJ; Cichutek K
    J Gene Med; 2006 Oct; 8(10):1274-6. PubMed ID: 17001625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy resumes.
    Novak K
    Nat Rev Cancer; 2002 Nov; 2(11):813. PubMed ID: 12442759
    [No Abstract]   [Full Text] [Related]  

  • 6. Looking into the safety of AAV vectors.
    Kay MA; Nakai H
    Nature; 2003 Jul; 424(6946):251. PubMed ID: 12867952
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical research. Gene therapy a suspect in leukemia-like disease.
    Marshall E
    Science; 2002 Oct; 298(5591):34-5. PubMed ID: 12364755
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic modification of hematopoietic cells using retroviral and lentiviral vectors: safety considerations for vector design and delivery into target cells.
    Dropulic B
    Curr Hematol Rep; 2005 Jul; 4(4):300-4. PubMed ID: 16009045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. US panel advises resumption of gene trials.
    Fox JL
    Nat Biotechnol; 2002 Nov; 20(11):1068-9. PubMed ID: 12410240
    [No Abstract]   [Full Text] [Related]  

  • 10. Bubble babies and bathwater.
    Nat Biotechnol; 2002 Nov; 20(11):1063. PubMed ID: 12410236
    [No Abstract]   [Full Text] [Related]  

  • 11. Is retroviral gene marking too dangerous to use?
    Brenner MK; Heslop HE
    Cytotherapy; 2003; 5(3):190-3. PubMed ID: 12850996
    [No Abstract]   [Full Text] [Related]  

  • 12. Medicine. Gene therapy--new challenges ahead.
    Williams DA; Baum C
    Science; 2003 Oct; 302(5644):400-1. PubMed ID: 14563994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy. Second child in French trial is found to have leukemia.
    Marshall E
    Science; 2003 Jan; 299(5605):320. PubMed ID: 12531981
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene therapy. What to do when clear success comes with an unclear risk?
    Marshall E
    Science; 2002 Oct; 298(5593):510-1. PubMed ID: 12386304
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy on trial.
    Hughes V
    Nat Med; 2007 Sep; 13(9):1008-9. PubMed ID: 17828211
    [No Abstract]   [Full Text] [Related]  

  • 16. Good news for gene therapy.
    Berns A
    N Engl J Med; 2004 Apr; 350(16):1679-80. PubMed ID: 15084702
    [No Abstract]   [Full Text] [Related]  

  • 17. Risks and benefits of gene therapy.
    Noguchi P
    N Engl J Med; 2003 Jan; 348(3):193-4. PubMed ID: 12529458
    [No Abstract]   [Full Text] [Related]  

  • 18. A tragic setback.
    Check E
    Nature; 2002 Nov; 420(6912):116-8. PubMed ID: 12432357
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene therapy insertional mutagenesis insights.
    Davé UP; Jenkins NA; Copeland NG
    Science; 2004 Jan; 303(5656):333. PubMed ID: 14726584
    [No Abstract]   [Full Text] [Related]  

  • 20. Insertional mutagenesis and development of malignancies induced by integrating gene delivery systems: implications for the design of safer gene-based interventions in patients.
    Romano G; Marino IR; Pentimalli F; Adamo V; Giordano A
    Drug News Perspect; 2009 May; 22(4):185-96. PubMed ID: 19536363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.